NCT00140712View on ClinicalTrials.gov

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 10, 2005

Primary Completion Date

February 28, 2008

Study Completion Date

February 28, 2008

Conditions
Restless Legs Syndrome
Interventions
DRUG

Ropinirole Immediate Release

Ropinirole Immediate Release

Trial Locations (9)

1020

GSK Investigational Site, Brussels

20010

GSK Investigational Site, Washington D.C.

27599

GSK Investigational Site, Chapel Hill

31201

GSK Investigational Site, Macon

40202

GSK Investigational Site, Louisville

60611

GSK Investigational Site, Chicago

64108

GSK Investigational Site, Kansas City

75019

GSK Investigational Site, Paris

08818

GSK Investigational Site, Edison

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY